Patent Issued for 2,4-dinitrophenol formulations and methods using same (USPTO 11883369).

MLA

“Patent Issued for 2,4-Dinitrophenol Formulations and Methods Using Same (USPTO 11883369).” Hepatitis Weekly, Feb. 2024, p. 1353. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=175468524&authtype=sso&custid=ns315887.

APA

Patent Issued for 2,4-dinitrophenol formulations and methods using same (USPTO 11883369). (2024). Hepatitis Weekly, 1353.

Chicago

“Patent Issued for 2,4-Dinitrophenol Formulations and Methods Using Same (USPTO 11883369).” 2024. Hepatitis Weekly, February, 1353. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=175468524&authtype=sso&custid=ns315887.